Brought to you by 
AMD device developer NeoVista achieves $41mm via third round
20 Dec 2006
Executive Summary
NeoVista (eye devices) has raised $41mm through its Series C financing. The oversubscribed round was led by new investor Essex Woodlands Health Ventures, which was joined by fellow new backer MPM Capital and returning shareholders Versant Ventures, SV Life Sciences, Carlyle Group, and Accuitive Medical Ventures.
Deal Industry
- Medical Devices
-
Medical Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
-
Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
AMD device developer NeoVista achieves $41mm via third round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice